Cytomegalovirus as a risk factor for TB and leishmaniasis
Dr Lisa Stockdale, University of Oxford, UK
Daniel Mekonnen Poster 2024
Daphne Jackson Fellowships
Fellowships for those looking to return to a research career after a break of two or more years for family, health or caring reasons. The aim is to give participants the confidence and skills they need to make a successful return to research.
Data Resources
Dataking Consulting
United Kingdom
Debre Markos University
Ethiopia
Deepa Paliwal 2019
Defence Research and Development Organisation
India
Defence Science and Technology Laboratory
United Kingdom
Defining Correlates of Humoral Immunity Against Inhalational Melioidosis
Defining the mechanism of BCG-priming and its impact on subunit vaccine boosting
Dr Elena Stylianou, University of Oxford, UK
Deltamune - Biotechnology
South Africa
Department of Agriculture, Land Reform & Rural Development (South Africa)
South Africa
Department of Health, County Government of Kisumu
Kenya
Design and development of an open-source ELISpot reader enabled by 3D printing
Dr Andy Tran, City St George's, University of London (SGUL), United Kingdom (UK)
Determining the metabolic impact of BCG vaccination
Dr Mrinal Kumar Das, University of Leicester, UK
Develop interdisciplinary research proposals to tackle epidemic threats
19 June 2025, 4:00pm to 4:00pm
Apply for seed funding to build interdisciplinary teams and develop research ideas to tackle epidemic diseases of animals, humans and plants.
Developing a mouse model of diabetes to evaluate vaccines for TB and melioidosis
Dr Elena Stylianou, University of Oxford, UK
Developing a vaccine for Melioidosis: Probing the protective immune response
with Prof Siobhán McClean & Dr Julen Tomás Cortázar, UCD
Developing a vaccine for Melioidosis:Probing the protective immune response
30 June 2020, 3:00pm to 5:00pm
Prof Siobhán McClean and Dr Julen Tomás Cortázar discussed their progress towards a vaccine for Burkholderia pseudomallei, the bacteria that causes Melioidosis.
Development of an RNA based vaccine against Mycobacterium tuberculosis
Affiliate Prof Rhea Coler, Center for Global Infectious Disease Research, Seattle Children's Research Institute, USA
Development of Versatile and Cost-Effective Next-Generation Vaccines through Multivalent Approaches
Dr Julen Tomás Cortázar, University College Dublin, Ireland